The doctor in this case prescribed Risperidone depot but told the patient he had been given Clopixol depot, as “covert medication”. She was then sacked, after being treated atrociously by her employer: Dr A Malik v CAS (Cygnet) Behavioural Health Ltd [2021] UKET 2403141/2018.
She admitted misconduct at the Medical Practitioners Tribunal but it found her not to be impaired: Ambreen Malik [2021] MHLO 8 (MPT). That tribunal originally published its decision but it is no longer on the internet. It would be interesting to see what was said about the ambit of covert medication, particularly the distinction between giving medication completely secretly and claiming that medication X is medication Y. The tribunal rejected my FOI request that it be republished. See the case page for a link to the What Do They Know request, but I’ll set out extracts below.
If anyone has any Freedom of Information Act experience could you please let me know? I haven’t had time to read the cases referred to in their refusal, but I was wondering whether to ask for a redacted decision (showing the ethical/legal issues and hiding any irrelevant personal information). Thanks in anticipation.
FOI request:
On 2 December 2024 I asked the MPTS for a copy of the decision following the hearing on 15 July 2021. On 2 January 2025 the GMC refused (ref IR1-4692950634), citing s40(2) and s40(3A)(a) FOIA 2000.
I would like you to review this decision:
The MPTS decision was previously published: see Dr Ambreen Zahoor MALIK GMC ref. no. 6066144 - copy of MPT determination - a Freedom of Information request to General Medical Council - WhatDoTheyKnow
Details of the MPTS hearing were reported in the press at the time: for example, see Blackburn psychiatrist cleared of misconduct after lying about medication - LancsLive
Although the finding was “not impaired”, the doctor admitted misconduct (see final paragraph of the article above).
The Employment Tribunal has published a 434-paragraph decision giving full details, and a 56-paragraph reconsideration: see Dr A Malik v CAS Behavioural Health Ltd and Signet Healthcare Ltd: 2403141/2018 - GOV.UK
Covert medication involves complicated legal issues, and it would be in the public interest for the reasons given by the MPTS to be known.
Refusal:
I have considered the matter from first principles again, including the points you raised, but I confirm that I agree with the decision of Ms Janghir. In doing so, I want to make clear that I completely accept that the decision was once public, there is reporting about it available to read now, Dr Malik admitted misconduct and there are two public employment tribunal decisions in the public domain concerning him.
As previously explained, the GMC treats complaints made about doctors as confidential. If a case progresses to a hearing, or an investigation concludes with a warning or undertakings, certain information may be made publicly available by the GMC, in line with our publication and disclosure policy for fitness to practise information. A key part of the policy is time limited publication.
There is only one legal basis which could theoretically provide the justification for providing you with the information you seek. It is referred to as ‘Legitimate Interests.’ In order for this to apply, there is a three part test. The test would be met if you are pursuing a legitimate interest, processing is necessary for the pursuance of that purpose and the interest in providing the information outweighs the rights and freedoms of Dr Malik. The ICO’s guidance in respect of the exemption Ms Janghir applied-section 40, including the test referred to above, is here.
I now turn to considering the test to determine if disclosure is legal. I accept that you are pursuing a legitimate interest. There is a general interest in transparency, accountability and the fair and proper administration of regulation. There may well be a specific interest in this case because of the issues it related to as well.
However, it isn’t obvious to me that providing the material you seek is reasonably necessary to meet all these objectives.
The GMC’s publication and disclosure policy attempts to strike a careful balance between transparency and accountability, it’s data protection obligations and the rights of all people whose personal data we process. Publishing the material we do in line with the policy (when taken along with all of the other information we publish) meets the objective. In respect of the fair and proper administration of justice, I would point out that some other judicial, regulatory, or similar bodies do not publish the reasoning for their decisions or do so on a time limited basis. The GMC is not an outlier in this respect.
Furthermore, while I accept that there may be a special interest in this case, it isn’t obvious to me that it is of any more importance that other types of allegations that could be considered by a tribunal.
If the material you seek isn’t necessary to meet the objectives pursued, the application of the test ends and the request fails. However, if it were to be found that providing the material you seek was necessary, I believe your request fails on the third part of the test.
I appreciate that there is reference to the tribunal in the public domain. However, the full contents of the determination are not public and so what is being requested goes significantly beyond what is available publicly and is against our publication and disclosure policy. The policy influences doctors legitimate expectations about the information we make public about them and for how long. Any doctor who had information published about them outside of out policy would likely feel a measure of distress about this- especially, as in this case, where the doctor was found not to be impaired and the disclosure to you under FOIA would be to the public at large, forever. I have considered the idea that because there is some information in the public domain already, the doctors distress may be less than it otherwise be. However, I do not find it persuasive because the material requested goes so much further than what is public.
My thinking has been influenced by this first tier decision which dealt with a request for once published tribunal determinations out with the GMC’s policy, in which the GMC applied S40(2) of FOIA. It was agreed that the GMC was correct in not providing the determination. The requester appealed to the Upper Tribunal, who rejected the appeal here.
I understand that this decision will be disappointing to you but I hope that I have explained how we have made it within the boundaries of accepted case law. To make any other decision would leave the GMC open to potential legal challenge by publishing material in breach of the doctors data protection rights.